Research & Clinical Evidence

Proven, not promised. Open the evidence.

Every TITN device is mapped to its FDA regulatory tier, its coverage position, and the peer-reviewed literature behind it. The 510(k) records, CMS coverage references, and DOIs are all linked below. Credibility you can check, not claims you have to trust.

Sources verified: August 27, 2026 · Next review: August 27, 2027
Diagnostic Platform 01

WAVi Scan System (EEG/ERP)

FDA 510(k) cleared (K213900) for acquisition, display, and storage of EEG and event-related potentials to aid in diagnosis, not to diagnose any condition on its own. Used for quantified brain measures and longitudinal baseline-to-retest tracking; the clinician interprets.

FDA Clearance & Reimbursement
WAVi Co, Inc. · Class II medical device
510(k) cleared
FDA 510(k) record
K213900 · WAVi SCAN software, indicated for acquisition, display, and storage of EEG and event-related potentials to aid in diagnosis, not to diagnose any condition on its own.
View FDA 510(k) record →
Coverage and coding
  • The scan is billed under the standard codes for the services performed, and your payer decides each line. The physician's cognitive assessment visit is billed separately, only when it is performed and documented.
  • Coverage depends on your contractor's policy, the documented indication, the equipment and method, and the interpreting physician.
  • Ask us for the coverage checklist and the one page worksheet, and confirm every code with your certified coder before the first claim.

Read your contractor's policy in the CMS Medicare Coverage Database before billing.

Indications for use (verbatim)
"The WAVi SCAN software is intended for the acquisition, display, and storage of electrical activity of a patient's brain including electroencephalograph (EEG) and event-related potentials (ERP) to aid in diagnosis."
Source: WAVi Scan Manual IFU (PDF) →
Peer-reviewed clinical context
Foundational EEG and ERP literature
What TITN claims: WAVi captures EEG and ERP data to aid in clinical diagnosis. Coverage is decided by the payer on the documented indication.
What TITN does not claim: WAVi does not diagnose any condition as a standalone test; it records EEG and ERP measures. Interpretation remains the clinician's responsibility. The withdrawn K162460 Research Desktop variant is not marketed.
Diagnostic Platform 02

TM-Flow System (ANS, SUDO, ABI)

Three-module integrated workstation, each module independently FDA 510(k) cleared. Manufactured by LD Technology. Covers autonomic function, sudomotor activity, and ankle-brachial index in one session, about ten minutes in our placements.

Three FDA 510(k) clearances
LD Technology, LLC · Class II medical device
510(k) × 3
Module 1 · TBL-ABI (vascular)
K173696 · Ankle-brachial index, pulse volume recording, plethysmography for PAD screening.
View FDA record → · Manufacturer announcement
Module 2 · SudoC (sudomotor)
K152216 · Galvanic skin response for sudomotor / sweat gland function assessment.
View FDA record →
Module 3 · Oxi-W (HRV / PPG / endothelial)
K200141 · SpO2, pulse rate, photoplethysmography waveform analysis, HRV, endothelial function analysis.
View FDA record →
Coverage and coding
  • Coverage is decided by your Medicare contractor and each commercial plan, on the documented indication, the equipment used, and the interpreting physician's training. Four contractors publish an autonomic policy; Noridian (California) publishes none.
  • TITN recommends no code. Confirm every code with your certified coder before the first claim.
Peer-reviewed clinical context
Autonomic neuropathy + PAD literature
What TITN claims: TM-Flow integrates three independently cleared modules. It supports PAD screening, sudomotor function measurement, and autonomic function assessment per the cleared indications of each module.
What TITN does not claim: TM-Flow does not diagnose diabetic neuropathy as a standalone test. "ANS+" is TITN's program name, not the cleared device name, which is TM-Flow System. Reimbursement is not guaranteed and depends on meeting LCD coverage criteria.
Diagnostic Platform 03

Max Pulse (Cardiovascular)

Pulse-wave cardiovascular screening at chairside; the manufacturer describes waveform pattern as an indicator of arterial flexibility. About one to three minutes in our placements, with an immediate report.

Regulatory status
Wellness screening positioning
FDA 510(k) K110374
US FDA 510(k) status
The Max Pulse is cleared under FDA 510(k) K110374. TITN positions it as a cash-pay cardiovascular wellness screening; any insurance billing must be payer-confirmed.
What TITN claims: Fast chairside pulse-wave screening tool that outputs heart rate and a pulse waveform, useful as part of a longitudinal cardiovascular wellness program. Arterial stiffness interpretation of the waveform pattern is the manufacturer's characterization, not an independent clinical validation.
What TITN does not claim: Max Pulse is a screening tool, not a replacement for a formal cardiac diagnostic workup. Insurance billing must be payer-confirmed.
General pulse-wave research
Foundational arterial stiffness literature

Pulse wave velocity and augmentation index are established vascular biomarkers described in the cardiology literature (Laurent S, et al., 2006, Expert consensus document on arterial stiffness: methodological issues and clinical applications, Eur Heart J; PubMed 17000623). We cite the device by its FDA 510(k) number (K110374) and do not claim device-specific validation studies beyond what the manufacturer or independent investigators have published.

Treatment Platform 01

ALTMS / BLOSSOM TMS

FDA 510(k) cleared rTMS therapy for adults with Major Depressive Disorder who have failed prior antidepressants. Billed as a course of care when coverage criteria are met.

FDA Clearance & Reimbursement
REMED Co Ltd · Class II medical device
510(k) cleared
FDA 510(k) record
K220625 · ALTMS / BLOSSOM TMS, repetitive transcranial magnetic stimulation indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode.
View FDA 510(k) record →
Coverage
A course of ALTMS treatment is billed as a course of care when coverage criteria are met: initial mapping and motor threshold determination, the subsequent delivery sessions, and any motor threshold re-determination. Confirm the codes and the criteria with your certified coder before the first claim.

Coverage criteria per CMS LCD L34998 and billing article A57072.

Peer-reviewed clinical evidence
TMS for MDD pivotal trials and consensus
What TITN claims: ALTMS is cleared for adults with treatment-resistant Major Depressive Disorder. It is billed as a course of care when coverage criteria are met.
What TITN does not claim: US marketing of ALTMS does not extend to epilepsy, OCD, Parkinson's, tinnitus, MS, panic, or hallucinations, even where those indications appear in the Korean IFU.
Treatment Platform 02 · General Wellness

Hue Light USA Suite (BAHI Protocol)

The Hue Light USA suite operates exclusively under the FDA General Wellness policy for low-risk devices. These products are not FDA cleared. The peer-reviewed citations below describe the underlying mechanism research for each modality; they are not Hue Light-specific clinical claims.

PBM Bed (Photobiomodulation)
38,880 LEDs · 530 / 660 / 850 / 940 nm
General Wellness
Mechanism research
What TITN does not claim for the PBM Bed: Therapy modality CPT codes (e.g., 97026, 97039), pain relief indications belonging to other manufacturers' cleared devices, or fat-loss / body-contouring claims.
H-2000 (Molecular Hydrogen)
Hydrogen inhalation device
General Wellness
Mechanism research
What TITN does not claim for H-2000: Treatment of COPD, inflammatory conditions, metabolic syndrome, or any disease indication. Wellness and relaxation positioning only.
H-Bot (Hyperbaric Chamber)
General wellness relaxation chamber
General Wellness
Clinical HBOT reference (separate domain)
  • Huang ET (ed). (2023). UHMS Hyperbaric Medicine Indications Manual, 15th Edition. Best Publishing Company for UHMS.
    uhms.org
  • Huang ET, et al. (2015). A clinical practice guideline for the use of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers. Undersea Hyperb Med.
    PubMed 26152105
What TITN does not claim for H-Bot: Clinical HBOT billing under NCD 20.29 codes (G0277, 99183, C1300) does not apply to H-Bot. No wound-care, autism, stroke, Lyme, cancer, or TBI claims. The cited HBOT literature applies to therapeutic-pressure clinical HBOT in FDA-cleared chambers, not to H-Bot.
Hue Light Wave Motion (WME-01)
Whole-body vibration platform
General Wellness
Mechanism research
What TITN does not claim for Wave Motion: Therapy modality CPT codes (97026, 97039), pain relief indications belonging to other manufacturers' cleared devices, or fat-loss / body-contouring claims.
Diagnostic Platform 04 · Molecular

Genetic Panels via PreCheckHealth

Clinical-grade genetic testing delivered by PreCheckHealth Services. Four provider-ordered panels covering pharmacogenomics, hereditary cancer, immunogenetics, and adult neurogenetics.

Lab Accreditation
PreCheckHealth Services · provider-ordered only
CLIA + CAP
CLIA certification
10D2210020 · Clinical Laboratory Improvement Amendments certified for high-complexity testing.
PreCheckHealth →
CAP accreditation
9101993 · College of American Pathologists accredited laboratory.
Four available panels
  • PharmacoCheck+ · Pharmacogenomics; drug-metabolizing enzyme variants for personalized medication selection
  • CancerCheck (PreCheckHealth's Comprehensive Hereditary Cancer Panel) · 116-gene hereditary cancer panel covering solid tumors, hematologic malignancies, and multi-system syndromes
  • ImmunoCheck (PreCheckHealth's immunogenetic panel) · 291-gene immunogenetic panel for inborn errors of immunity, dysregulated inflammation, autoimmune predisposition
  • Comprehensive Neurogenetic Panel · 203-gene adult panel covering epilepsy, neuromuscular, leukodystrophies, hereditary neuropathies, neurodegenerative
Clinical context
How TITN positions the genetic layer

All four panels are provider-ordered through PreCheckHealth, with genetic counseling available, scheduled by phone or email. PreCheckHealth bills insurance directly; TITN serves as a referral partner. The genetic data integrates with TITN's WAVi and TM-Flow records on the HIPAA-compliant patient portal.

Pharmacogenomics pairs cleanly with ALTMS treatment planning (psychiatric medication metabolism). The Neurogenetic Panel pairs with WAVi for genetic-plus-functional baseline assessment.

What TITN claims: The neurogenetic, hereditary cancer, and immunogenetic panels are processed by PreCheckHealth under its CLIA certification and CAP accreditation. All panels are provider-ordered, with genetic counseling available.
What TITN does not claim: Consumer SNP testing, ancestry analysis, or wellness positioning. These are clinical panels ordered by a physician for clinical use.
Compliance & Transparency

How we back what we publish.

Every claim on this page is intended to trace to one of these source tiers, and estimates or directional data are marked where used. Report a claim you cannot verify to support@transitionitnow.com.

Tier 1 · Government & primary literature

FDA 510(k) database (accessdata.fda.gov), CMS Physician Fee Schedule (PFS Look-Up), CMS Coverage Database (LCDs, NCDs, articles), peer-reviewed citations via PubMed and DOI.

Tier 2 · Manufacturer technical documentation

Device IFUs, manufacturer regulatory pages (LD Technology, WAVi Co, REMED), Hue Light USA technical specifications. Used for device specs, not for clinical efficacy claims.

What we do not claim

The TITN Forbidden Claims sheet lives in our internal regulatory documentation. Highlights are surfaced under each device above. Examples: WAVi does not diagnose; it records EEG and ERP measures a clinician interprets. TM-Flow modules are cited individually by K-number rather than collapsed, and Hue Light products operate exclusively under General Wellness scope.

Reimbursement disclaimer

Coverage references and Medicare PFS rates on this page are reference points only. Actual reimbursement varies by payer, plan, locality, and patient eligibility. CMS-published rates change annually. Verify locality-specific rates via the CMS PFS Look-Up before billing.

All Sources

Every URL on this page, in one list.

Live as of August 31, 2026. Next scheduled review: August 31, 2027. Spot a broken or outdated link? Email support@transitionitnow.com.

CMS coverage & reimbursement

  1. CMS Physician Fee Schedule Look-Up
  2. WAVi EEG/ERP coverage: billed under the standard codes for the services performed; coverage policies in the CMS Medicare Coverage Database
  3. LCD L34998 · TMS for MDD
  4. A57072 · TMS billing and coding
  5. A57651 · Autonomic Function Tests
  6. A57551 · Autonomic Function Testing
  7. NCD 20.29 · Hyperbaric Oxygen Therapy

Genetic panels · PreCheckHealth

  1. PreCheckHealth Services · home
  2. CLIA certification 10D2210020 · College of American Pathologists accreditation 9101993 (verifiable via CMS CLIA Look-Up and CAP directory).

Want a deeper clinical brief for your specialty?

Book a 15-minute call and we will walk through the evidence for the devices that fit your practice, with the reimbursement math worked out for your locality.

Book a call